• EPH106 Prevalence and Patient Characteristics of Valvular Heart Disease in Heart Failure Hospitalization in Japan: Real-World Claims Data Analysis

    Jun 1, 2023, 00:00

  • CO158 Relationship between Overall Response Rate (ORR), Progression-Free Survival (PFS), and Overall Survival (OS) in Clinical Trials of Patients with Mantle Cell Lymphoma (MCL)

    Jun 1, 2023, 00:00

  • PCR99 Regular COVID-19 Booster Shot Preference and Willingness to Pay in the Vietnamese Population: A Theory-Driven Discrete Choice Experiment

    Jun 1, 2023, 00:00

  • HSD83 Hypertension and Pregnancy: Pharmacologic Treatment and Pregnancy Outcomes

    Jun 1, 2023, 00:00

  • HPR71 Variations in Medicare Advantage Prior Authorization Policies for High-Cost Oncology Immunotherapies

    Jun 1, 2023, 00:00

  • RWD27 Disparities in Incidence, Real World Treatment Patterns, and Medication Adherence Among Patients with Systemic Lupus Erythematosus (SLE) in the US: A Retrospective Claims and Electronic Health Records Analysis

    Jun 1, 2023, 00:00

  • EPH109 Excess Mortality from Diabetes Mellitus in the First Year of the Pandemic in Colombia

    Jun 1, 2023, 00:00

  • P56 Comparison of Methods for Incorporating Time-to-Event Outcomes in Budget Impact Analyses

    Jun 1, 2023, 00:00

  • MSR5 Distribution of the Annual Costs of a Cohort of Patients with Diabetes in a Large Colombian Health Insurer

    Jun 1, 2023, 00:00

  • EE297 Impact of Breathlessness Severity on Quality of Life, Healthcare Use, Productivity Loss and Economic Cost to the Australian Society

    Jun 1, 2023, 00:00

  • EE62 Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in Germany

    Jun 1, 2023, 00:00

  • P18 A Review of HTA Guidelines on Societal and Novel Value Elements

    Jun 1, 2023, 00:00

  • MSR64 Psychometric Validation of the Electronic Hidradenitis Suppurativa Quality of Life (eHiSQOL) Questionnaire Using Pooled Data from the Phase 3 BE HEARD Trials of Bimekizumab in Hidradenitis Suppurativa

    Jun 1, 2023, 00:00

  • PCR243 Exploring Health Outcomes By Occupation: Using the National Health and Wellness Survey to Describe Differences in Self-Reported Occupation Profiles

    Jun 1, 2023, 00:00

  • EPH82 Racial Differences in Adverse Outcomes Following Androgen Deprivation Therapy for Prostate Cancer

    Jun 1, 2023, 00:00

  • P20 An Evaluation of Special Considerations in the Assessment and Decision-Making Processes across HTA Agencies for Drugs for Rare Diseases

    Jun 1, 2023, 00:00

  • HSD33 Medical Costs, Hospitalizations, and Length of Stay Associated with Discontinuations in Cycled Oral Antineoplastics Among Medicare-Eligible Oncology Patients

    Jun 1, 2023, 00:00

  • EE500 Cost-Effectiveness Analysis of Cemiplimab As Second-Line Therapy for Recurrent Cervical Cancer in Japan

    Jun 1, 2023, 00:00

  • P52 Barriers to Reducing Time to Diagnosis and Treatment in Rare Disease

    Jun 1, 2023, 00:00

  • CO226 Chimeric Antigen Receptor T-Cell (CAR-T) Therapy for Multiple Myeloma in the US: Real-World Evaluation of Patient Characteristics and Treatment Patterns

    Jun 1, 2023, 00:00

  • Eliciting Trade-Offs Between Equity and Efficiency: A Methodological Scoping Review [Editor's Choice]

    Jun 1, 2023, 00:00

  • PCR74 Trends in the Inclusion of Patient Reported Outcomes in Oncology Clinical Trials: Analysis of ClinicalTrials.gov (2013-2022)

    Jun 1, 2023, 00:00

  • HTA100 What Is a Good or Bad Number Needed to Treat (NNT)? A 2022 Updated Literature Review

    Jun 1, 2023, 00:00

  • EPH257 Public Health Impact of UK COVID-19 Booster Vaccination during Omicron Predominance

    Jun 1, 2023, 00:00

  • EE152 Cost-Effectiveness Modeling of Lurbinectedin As a Second-Line Therapy in Patients with Small Cell Lung Cancer (SCLC)

    Jun 1, 2023, 00:00

  • CO165 Comparison of Non-Robotic Surgery Vs. Robot-Assisted Surgery for Radical Prostatectomy

    Jun 1, 2023, 00:00

  • EE86 Cost-Effectiveness Analysis of Axicabtagene Ciloleucel, Lisocabtagene Maraleucel, and Tisagenlecleucel CAR T-Cell Therapies for Treatment of Relapsed or Refractory Large B-Cell Lymphoma (LBCL)

    Jun 1, 2023, 00:00

  • MT49 Watch on the Dash – A CEA Tool of LAAC for Atrial Fibrillation in the Brazilian Healthcare System

    Jun 1, 2023, 00:00

  • EPH247 Pain and Arthralgia Adverse Events Associated with Crizanlizumab and Voxelotor: Disproportionality Analysis of US FDA Adverse Events Reporting System (FAERS)

    Jun 1, 2023, 00:00

  • EE184 Economic Burden of Cystic Fibrosis in the United States: A Systematic Review

    Jun 1, 2023, 00:00

  • EPH17 Prevalence of Perinatal Depression Among Rural Women in Yunnan Province, China: A Population-Based Screening Programme

    Jun 1, 2023, 00:00

  • EE306 The Burden of Disease of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Costa Rica

    Jun 1, 2023, 00:00

  • MSR56 A Supplementary Search to Identify Additional Relevant Literature Not Captured in a Systematic Literature Review Search Strategy

    Jun 1, 2023, 00:00

  • EE529 Characterizing Attack-Related Health Utility in Hereditary Angioedema

    Jun 1, 2023, 00:00

  • MT26 Evaluating the Impact of Digital Proms Collection in an Outpatient Breast Cancer Clinic: A Feasibility Pilot

    Jun 1, 2023, 00:00

  • PCR118 Quantifying Patient Preferences for Targeted Therapies in Metastatic Melanoma: A Discrete-Choice Experiment

    Jun 1, 2023, 00:00

  • EE251 Drug Expenditure, Price, and Utilization in the U.S. Medicaid Program: An Empirical Trend Analysis for Nonbiologic and Biologic DMARDS

    Jun 1, 2023, 00:00

  • EPH181 An Analysis of Patient Characteristics Associated with Myelosuppression Among Small Cell Lung Cancer (SCLC) Patients Treated in US Community Cancer Care Practices

    Jun 1, 2023, 00:00

  • EE19 Cost-Effectiveness Analysis of Nonpharmaceutical Interventions Combined with Inactivated Vaccination and Oral Medicine in China

    Jun 1, 2023, 00:00

  • EE12 Diagnosing Irritable Bowel Syndrome (IBS): A Real-World Study to Assess Resource Utilization

    Jun 1, 2023, 00:00

  • RWD132 A Real-World Evidence Study on the Chronic Obstructive Pulmonary Disease Treatments Submitted to the Brazilian National Committee for Health Technology Incorporation

    Jun 1, 2023, 00:00

  • EPH34 Trends in Prescription Contraceptive Use Among US Commercially Insured Women, 2017 – 2021

    Jun 1, 2023, 00:00

  • EPH93 Traceability of Infliximab Reference Medicinal Product and Its Biosimilar Products Adverse Drug Events Reports in Saudi Arabia

    Jun 1, 2023, 00:00

  • EE217 Efficiency-Equity Trade-Offs in Cost-Effectiveness Analyses: An Umbrella Review of Previous Systematic Literature Reviews

    Jun 1, 2023, 00:00

  • EPH70 Trends in Hospitalizations Related to Anxiety, Depression, and/or Substance Use Among Adult Inpatients from 2016-2020 in the United States

    Jun 1, 2023, 00:00

  • HPR57 Evidence Demonstration Framework for Medicare Part B and D Products Subject to Inflation Reduction Act (IRA) Price Regulations

    Jun 1, 2023, 00:00

  • EE74 The Burden of Disease of Diabetic Macular Edema and Neovascular Age-Related Macular Degeneration in Panama

    Jun 1, 2023, 00:00

  • EE528 Healthcare Resource Utilization Among Patients with Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in England

    Jun 1, 2023, 00:00

  • EE374 Expected Cost of an FDA-Authorized Prescription Digital Therapy for Children with ADHD

    Jun 1, 2023, 00:00

  • PCR30 The Burden of Familial Chylomicronemia Syndrome (FCS) in Brazilian Patients – A Pilot Qualitative Study

    Jun 1, 2023, 00:00

  • RWD64 Reduction of Biologic Pricing Following Biosimilar Introduction

    Jun 1, 2023, 00:00

  • P7 Racial and Ethnic Differences in the Use and Discontinuation of Long-Acting Injectable Antipsychotics

    Jun 1, 2023, 00:00

  • CO216 Understanding the Real-World Clinical Effectiveness of Pegcetacoplan for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH)

    Jun 1, 2023, 00:00

  • CO204 Primary and Secondary Endpoints Used in Recent (2022) Alzheimer’s Disease (AD) Phase III Clinical Trials

    Jun 1, 2023, 00:00

  • EE452 The Economic Impact on the Introduction of the Antidote N-Acetylcysteine in the Management of Acute Paracetamol Intoxication in Algeria

    Jun 1, 2023, 00:00

  • EE162 Healthcare Resource Utilization and 2022 Cost Update of Cytokine Release Syndrome and Neurotoxicity in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Idecabtagene Vicleucel (IDE-CEL, BB2121) in KarMMa

    Jun 1, 2023, 00:00

  • EPH5 Validity and Accuracy of Weight Status-Related Diagnosis Codes Among Hospitalized Patients in the United States: 2017−2021

    Jun 1, 2023, 00:00

  • PCR173 Predictors of Pediatric Emergency Department (ED) Visits for the Acute Ambulatory Care Sensitive Conditions (ACSC)

    Jun 1, 2023, 00:00

  • PCR119 The Impacts of Age and Gender on Mapped EQ-5D-5L Utilities and Quality-Adjusted Life Years (QALYS) in Cancer Clinical Trials

    Jun 1, 2023, 00:00

  • EPH144 Exploring Variables Associated with Multimorbidity Status Among Older US Adults with Self-Reported Pain and Opioid Use

    Jun 1, 2023, 00:00

  • HPR97 Inpatient Policies and Requirements for the Reimbursement of Novel Therapies Outside the Drg in the US and EU5

    Jun 1, 2023, 00:00

  • CO209 Association between Baseline Bone Mineral Density Testing and the Risk of Fractures in Men Initiating Androgen Deprivation Therapy: Population-Based Study

    Jun 1, 2023, 00:00

  • EE351 Comparing Real-Time Continuous Glucose Monitoring with Self-Monitoring of Blood Glucose in People with Type 1 Diabetes on Insulin Therapy: A Cost-Utility Study

    Jun 1, 2023, 00:00

  • MSR44 Non-Randomized Studies in Comparative Effectiveness Research; How Systematically Are They Identified By Existing Search Filters? Results from a Systematic Literature Review

    Jun 1, 2023, 00:00

  • HPR157 Payer Perspectives on Health Insurance Coverage for Digital Therapeutics in the United States

    Jun 1, 2023, 00:00

  • RWD77 $0 Drug Copay Program Increases Generic Drug Use Among Members with Diabetes in Louisiana: Six-Month Outcomes Analysis

    Jun 1, 2023, 00:00

  • EE321 Cost Impact of Next Generation Sequencing Testing in NSCLC with and without RNA Sequencing

    Jun 1, 2023, 00:00

  • Epidemiology Public Health

    Jun 1, 2023, 00:00

  • EPH80 Predicting Anxiety and Depression in the First Year Following Breast Cancer Diagnosis Using a Large Administrative Claims Data

    Jun 1, 2023, 00:00

  • HSD62 An Analysis of Asthma Care Pathways and Patient Outcomes in an East London Population Cohort: A Longitudinal Analysis Using Routinely Collected Data

    Jun 1, 2023, 00:00

  • RWD45 Global Pricing Trends of Hepatitis C Medications

    Jun 1, 2023, 00:00

  • RWD129 Work, Productivity, and Activity Impairment in Patients with Immunoglobulin a Nephropathy: Results from a Real-World Study

    Jun 1, 2023, 00:00

  • EPH166 The Effect of COVID-19 on Maternal and Neonatal Outcomes in a Large Tertiary Health System in Saudi Arabia

    Jun 1, 2023, 00:00

  • RWD180 What Does Healthcare Resource Utilization Look like in the General Population of the US? A Real-World Analysis Using Claims Data

    Jun 1, 2023, 00:00

  • EPH182 Disparities in Early Diagnosis, Treatment, and Survival Outcomes Among Patients with Early-Onset Colorectal Cancer in Texas

    Jun 1, 2023, 00:00

  • SA49 Virological Suppression in People Living with HIV-1 (PLWH) Receiving Dolutegravir/Lamivudine Was High and Similar across Age Groups Despite Older Plwh Having Increased Rates of Comorbidities and Polypharmacy (TANDEM SUBGROUP)

    Jun 1, 2023, 00:00

  • HPR112 Systematic Review for Rare Diseases Policy: A Sight in Peru and Colombia

    Jun 1, 2023, 00:00

  • HPR90 Sustainability of Biosimilars Medicines Policies in Brazil

    Jun 1, 2023, 00:00

  • PCR187 Patient and Physician Satisfaction of Treatment with Eculizumab or Ravulizumab in Paroxysmal Nocturnal Hemoglobinuria: Results from a Real-World Disease-Specific Programme

    Jun 1, 2023, 00:00

  • CO25 Impact of Novel Anti-Tumor Therapies on Mortality in Various Oncology Indications across EU5

    Jun 1, 2023, 00:00

  • HPR15 Is Drug Novelty Associated with Greater Health Benefits?

    Jun 1, 2023, 00:00

  • EE365 Cost-Utility Analysis of Early Reconstruction Surgery Versus Rehabilitation and Delayed Reconstruction for Anterior Cruciate Ligament Tears in Low and Middle-Income Country

    Jun 1, 2023, 00:00

  • PCR35 Asthma Management Support Needs Among Young Adults: A Pilot Qualitative Study

    Jun 1, 2023, 00:00

  • EE553 Estimating the Economic Burden of Progressive Multifocal Leukoencephalopathy in the United States: A Literature Review and Assessment

    Jun 1, 2023, 00:00

  • EE341 Cost Effectiveness of Sodium Zirconium Cyclosilicate for the Treatment of Hyperkalemia in Mexico

    Jun 1, 2023, 00:00

  • EPH235 Impact of Pharmacist-Led Interventions on Medication-Related Outcomes Among Cancer Patients: A Systematic Review

    Jun 1, 2023, 00:00

  • EE315 Trends in Medical Expenditure and Resource Utilization Among Opioid, Benzodiazepine, Skeletal Muscle Relaxant, and Gabapentin Users: A Pooled Cross Sectional Analysis from 2009 - 2019

    Jun 1, 2023, 00:00

  • EE367 Cost-Effectiveness Analysis of Different Treatment Strategies for Schizophrenia in China

    Jun 1, 2023, 00:00

  • EE78 Budget Impact Analysis of Proactive Therapeutic Drug Monitoring for Inflammatory Bowel Disease Patients in the United States on Infliximab Therapy

    Jun 1, 2023, 00:00

  • CO208 Recurrence Rates and Survival Among Patients with Early-Stage Cancers: A Systematic Literature Review

    Jun 1, 2023, 00:00

  • CO151 Impact of the Rational Antibiotic Use System on Hospital Performance at Cartagena Colombia from 2018 to 2021

    Jun 1, 2023, 00:00

  • HSD39 Demodex Blepharitis Patient Journey: A Medical Chart Audit Study

    Jun 1, 2023, 00:00

  • CO107 Physical Therapy Versus Watchful Waiting for the Treatment of Adhesive Capsulitis of the Shoulder: A Prospective Randomized Controlled Trial

    Jun 1, 2023, 00:00

  • EPH225 Understanding the Relationship between Depression and Suicidal Tendencies Among Tertiary Students in Ghana

    Jun 1, 2023, 00:00

  • CO170 Baseline Characteristics, Including Hospitalizations, of Asthma Patients Treated with Dupilumab in the Real World: The Rapid Registry

    Jun 1, 2023, 00:00

  • EPH174 Trends in Postpartum Depression before and during the COVID-19 Pandemic and Correlates of Treatment Choices: A Population-Based Retrospective Cohort Study

    Jun 1, 2023, 00:00

  • HTA15 Beyond Value Assessment: Payer Perceptions of ICER’s Policy Initiatives

    Jun 1, 2023, 00:00

  • SA3 Characteristics of Patients Treated with CAR-T Therapies across Multiple Indications Utilizing the TriNetX Network

    Jun 1, 2023, 00:00

  • HPR82 How Has Commercial Coverage of Specialty Drugs Changed over Time?

    Jun 1, 2023, 00:00

  • HPR161 International Comparisons of Health Technology Assessment and Reimbursement Outcomes for Oncology Drugs with Regulatory Review through Project Orbis

    Jun 1, 2023, 00:00

  • EPH226 Medical Cost and Prevalence of Mental Diseases across Different Health Insurance Systems in Japan

    Jun 1, 2023, 00:00

  • PCR132 Symptoms and Impacts of Transfusion-Dependent Beta-Thalassemia: A Qualitative Interview Study and the Development of a Conceptual Model

    Jun 1, 2023, 00:00

  • RWD98 Understanding the Role of Real-World Evidence for Reimbursement and Market Access of Ultra Orphan Drugs: Insights and Lessons from Case Studies of NICE Highly Specialized Technology (HST) Assessment Reports

    Jun 1, 2023, 00:00

  • RWD140 Economic Burden of Post-ERCP Pancreatitis in Inpatient Setting Among Elderly Beneficiaries Enrolled in Traditional Medicare

    Jun 1, 2023, 00:00

  • PCR62 Post-Lockdown Behaviors and Impacts of Avoiding COVID-19 in Individuals and Caregivers of Individuals at High-Risk of Severe COVID-19: A Qualitative Study

    Jun 1, 2023, 00:00

  • EPH249 Development of Substance Use Disorder in Chronic Kidney Disease Patients Experiencing Uremic Pruritus

    Jun 1, 2023, 00:00

  • HPR49 The Inflation Reduction Act Exclusion Effect: An Analysis of Inflation Reduction Act Minimum-Discount Negotiation Rules

    Jun 1, 2023, 00:00

  • EPH125 Association of Sarcopenia with Functional Limitations and Caregiver Burden Among Chinese Elderly

    Jun 1, 2023, 00:00

  • EPH4 Validation of Novel Identification Algorithms for Nonfatal Myocardial Infarction Using Uniform Objective Criteria and Pooled Clinical Trial Data

    Jun 1, 2023, 00:00

  • HPR121 Impact of Mandatory Prescription Drug Monitoring Program in Polysubstance-Related Admission Rate in the Substance Abuse Treatment Facilities in the United States

    Jun 1, 2023, 00:00

  • EE282 Financial Burden of Progression of Chronic Myeloid Leukemia (CML) Patients Who Failed Two or More Tyrosine Kinase Inhibitors Treatment in the Brazilian Private Market Perspective

    Jun 1, 2023, 00:00

  • EE312 Cost-Effectiveness Analysis of the Transobturator Tape Compared to the Tension-Free Vaginal Tape Technique in the Correction of Patients with Stress Urinary Incontinence in an Institution of Medellín – Colombia

    Jun 1, 2023, 00:00

  • EPH13 Trends in Mortality Related to Hepatitis C in Colombia 1997 – 2020

    Jun 1, 2023, 00:00

  • EE362 Systematic Review of Individual-Level Simulation in Cost-Effectiveness Analysis of Antiviral Treatments in Patients with Hepatitis B

    Jun 1, 2023, 00:00

  • HPR91 The State of Cost-Effectiveness Analyses on Health Services and Procedures

    Jun 1, 2023, 00:00

  • EE279 Real-World Evidence Relating Cytopenia Diagnosis to Hospitalization and Cost of Care in the Treatment of Non-Small Cell Lung Cancer Patients

    Jun 1, 2023, 00:00

  • HTA88 A Systematic Literature Review of the Value of Prophylactic Treatment in Adult Patients with Hemophilia A

    Jun 1, 2023, 00:00

  • Disclosure Information

    Jun 1, 2023, 00:00

  • EE260 Cost-Effectiveness Analysis of Sacituzumab Govitecan As Second-Line Treatment for Metastatic Triple-Negative Breast Cancer in Japan

    Jun 1, 2023, 00:00

  • CO169 A Mixed Methods Approach to Characterize the Global Prevalence of Glycogen Storage Disease Type III and Associated Disease Complications

    Jun 1, 2023, 00:00

  • CO139 A Retrospective Study of Sglt-2 Inhibitors Prescription Disparities and Affordability Among Medicare Patients with Diabetes

    Jun 1, 2023, 00:00

  • HPR20 Are We Ready for Reimbursement of Software As a Medical Device in Asia-Pacific (APAC) Region?

    Jun 1, 2023, 00:00

  • PCR16 Patient-Reported Outcomes in Opioid Use Disorder (PR-OUD): Recommendations and Barriers in Clinical Trials and Studies

    Jun 1, 2023, 00:00

  • HSD75 What Features of Telehealth Are Important to Patients in HIV Care? A Systematic Literature Review

    Jun 1, 2023, 00:00

  • PCR172 Communicating Challenging Concepts in Preference Research: Developing and Testing a Discrete Choice Experiment (DCE) Survey in Metastatic Castration-Resistant Prostate Cancer (MCRPC)

    Jun 1, 2023, 00:00

  • EE489 The Economic Burden of Caring for a Child with Duchene Muscular Dystrophy in Canada: A Caregiver Survey

    Jun 1, 2023, 00:00

  • P11 Depression Severity Among Patients with Psychiatric Disorders during the COVID-19 Pandemic

    Jun 1, 2023, 00:00

  • Decisions and Deliberative Processes in Health Technology Assessment

    Jun 1, 2023, 00:00

  • EE67 The Financial Impact of a Newly Introduced Thermosetting, Bioadhesive, Antibacterial Hydrogel to U.S. Commercial and Medicaid Insurers in Treating Bacterial Vaginosis

    Jun 1, 2023, 00:00

  • EE439 Prevention of Needlestick Injuries and Blood Exposures Among Kenyan Healthcare Workers Using Safety Engineered Devices

    Jun 1, 2023, 00:00

  • EE122 The Economic Impact of a Psychosocial Utility Benefit Associated with Pre-Exposure Prophylaxis (PrEP) for COVID-19, in Immunocompromised (IC) Individuals – a Case Study for Future PrEP Evaluations

    Jun 1, 2023, 00:00

  • RWD127 Mapping the Flow of Biomarker Testing Information, from Test Order through Impact on Treatment Decision-Making: A Case Study in Metastatic NSCLC

    Jun 1, 2023, 00:00

  • EPH84 Administrative Claims-Based Algorithm to Identify Patients with Primary Sclerosing Cholangitis

    Jun 1, 2023, 00:00

  • HPR53 Uncovering Prescription Drug Pricing: Insights from Payer Price Transparency Regulations

    Jun 1, 2023, 00:00

  • EE99 Cost-Utility Analysis of 13-Valent Pneumococcal Conjugate Vaccine in the Immunization of Children Under Five Years for the Prevention of Invasive Pneumococcal Disease and Pneumonia in the Brazilian Public Healthcare System

    Jun 1, 2023, 00:00

  • EPH190 Cluster Analysis on RWD to Find Patterns of Multimorbidity: A Conceptual Framework

    Jun 1, 2023, 00:00

  • EE300 Clinical and Economic Burden of Exacerbations in Patients with Severe Asthma in South Korea

    Jun 1, 2023, 00:00

  • MSR73 Bayesian Hierarchical Models for Indirect Treatment Comparisons of Histology-Independent Therapies for Survival Outcomes

    Jun 1, 2023, 00:00

  • PCR159 The Clinical and Financial Impact of Blue Cross and Blue Shield of Louisiana Waiving Cost Share for the First Mental Health and Substance Use Disorder Follow-up Visit

    Jun 1, 2023, 00:00

  • EE238 Clinical and Economic Burden of Invasive Escherichia coli Disease Among Commercially Insured Adult Patients in the United States

    Jun 1, 2023, 00:00

  • MT46 Real World Use of Circulating Tumor DNA (CTDNA) in Colorectal Cancer (CRC): A Targeted Literature Review (TLR)

    Jun 1, 2023, 00:00

  • EE531 Evidence Generation Planning for and Economic Modeling of Rare Progressive Pediatric Diseases: Challenges and Prospective Solutions

    Jun 1, 2023, 00:00

  • HPR67 Ejadah: Implementation of Value-Based Healthcare in Emirate of Dubai

    Jun 1, 2023, 00:00

  • EPH38 Burden of Psychiatric Health in Elderly Myasthenia Gravis Patients: A Nationwide Medicare Perspective

    Jun 1, 2023, 00:00

  • SA43 Uptake of the Prisma 2020 Statement and Its Artificial Intelligence Component in Recently Published Systematic Reviews

    Jun 1, 2023, 00:00

  • PCR196 Designing Fit-for-Purpose Patient Preference Studies - A COA Developer Perspective

    Jun 1, 2023, 00:00

  • EE572 Intersection of Machine Learning and HEOR: A Systematic Review

    Jun 1, 2023, 00:00

  • RWD43 Comparison of All-Cause Healthcare Resource Utilization Rates between Patients with Type 2 Diabetes Who Use a Digital Diabetes Solution Versus Non-Users: A 12-Month Retrospective Cohort Study

    Jun 1, 2023, 00:00

  • EE544 Budget Impact Analysis of Faricimab for Treating Patients with Diabetes Macular Edema or Neovascular Age-Related Macular Degeneration in Guatemala

    Jun 1, 2023, 00:00

  • EE155 Burden of Illness of Adult Patients with Metastatic Colorectal Cancer Bearing the KRAS P.G12C Mutation - A Systematic Literature Review

    Jun 1, 2023, 00:00

  • MT16 Efficiency and User Satisfaction of Single-Use Vs Reusable Cystoscopes in a High-Volume Urology Clinic

    Jun 1, 2023, 00:00

  • Clinical Outcomes

    Jun 1, 2023, 00:00

  • RWD117 Economic Impact of Depression Among Medicare Beneficiaries (AGE ≥65 YEARS) with Alzheimer’s Disease and Related Dementia (ADRD) in the United States (US)

    Jun 1, 2023, 00:00

  • EPH107 Impact of Different Non-Invasive Tests on Estimated Prevalence of Presumed Nonalcoholic Steatohepatitis Among US Adults, NHANES 2017-2020

    Jun 1, 2023, 00:00

  • HPR13 Medicare Part B Spending on Biologics Due to Inadequate Biosimilar Uptake

    Jun 1, 2023, 00:00

  • HPR85 Determining the Pricing Checkpoints over an Originator's Lifecycle in China

    Jun 1, 2023, 00:00

  • P16 A Comparison of the Cox-Proportional Hazard Model and the Fine-Gray Model to Predict Survival in Patients with Non-Small Cell Lung Cancer (NSCLC)

    Jun 1, 2023, 00:00

  • HPR110 Risk Factors Associated with Repeat Pediatric Asthma Visits to Emergency Departments

    Jun 1, 2023, 00:00

  • EE463 Direct Medical Costs of Diabetes Mellitus in Colombia

    Jun 1, 2023, 00:00

  • HPR102 Exploring the Cost of Managing Diabetes in Nepal: A Cross-Sectional Analysis of Oral Hypoglycemic Medications

    Jun 1, 2023, 00:00

  • CO70 Matching Adjusted Indirect Comparison (MAIC) of Single Tremelimumab Regular Interval Durvalumab (STRIDE) Versus Atezolizumab with Bevacizumab (A+B) for the Treatment of Unresectable Hepatocellular Carcinoma (UHCC)

    Jun 1, 2023, 00:00

  • HPR87 Patient Assistance Programs for Genetic Testing: Closing the Underinsurance Gap or Widening Disparities?

    Jun 1, 2023, 00:00

  • CO136 Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged 6 and Older with Mild to Moderate Atopic Dermatitis in Two Phase 3 Integument Trials

    Jun 1, 2023, 00:00

  • EE295 Patient Financial Burden Following Discontinuation of Oral Pharmacotherapy: An Analysis of Treatment Options for Men with Erectile Dysfunction

    Jun 1, 2023, 00:00

  • EE467 Prescription Patterns and Estimation of Cost of Illness of Type-II Diabetic Patients in a Tertiary Care Hospital Nepal

    Jun 1, 2023, 00:00

  • EE436 Cystic Fibrosis Treatment Costs in a Brazilian Health Insurance Company

    Jun 1, 2023, 00:00

  • EE412 Analyzing the Financial Impact of a Remote Fetal Monitoring Solution Introduction for High-Risk Pregnancies in a US Obstetrics Clinic

    Jun 1, 2023, 00:00

  • EPH200 Sociodemographic and Clinical Characteristics of Patients with Alopecia Areata in Colombia: Data from the First National Registry

    Jun 1, 2023, 00:00

  • EE343 The Effect of BMI and the Obesity Paradox on Post-PCI Healthcare Costs and Length of Stay

    Jun 1, 2023, 00:00

  • HTA60 Potential Decision Drivers for Positive Recommendations of New Cancer Therapies in the Brazilian Private Healthcare System: Analysis of Recent HTA Submissions

    Jun 1, 2023, 00:00

  • EE4 Hospital Resource Use in below-Knee Surgical Bypass Procedures with Eptfe Vascular Grafts with Heparin End-Point Covalent Bond in Critical Limb Ischemia Peripheral Arterial Disease (PAD) Patients

    Jun 1, 2023, 00:00

  • EPH89 Analysis of the Effect of Healthy Migrant on Chronic Diseases and Its Associated Social Determinants of Health

    Jun 1, 2023, 00:00

  • HPR107 Landscape of Value-Based Contracting in Oncology

    Jun 1, 2023, 00:00

  • SA10 Benchmarking of Budget Impact Results: An Updated Systematic Review of US Budget Impact Analyses

    Jun 1, 2023, 00:00

  • HPR63 A Sneak Peek at the Medicare Part D Drugs Likely to be Targeted By CMS for Price Negotiation: Prediction Using Medicare Claims Data

    Jun 1, 2023, 00:00

  • RWD156 The Impact of the Sars-Cov-2 Pandemic (COVID-19) on the Incidence of Newly Diagnosed Multiple Myeloma Patients Using a Federated Network of Real-World Evidence in US and Germany

    Jun 1, 2023, 00:00

  • RWD152 Real-World Evidence on the Use of Ecmo in Hospitalized COVID-19 Patients: Results from a Linked Closed and Open Claims Database in the US

    Jun 1, 2023, 00:00

  • EPH114 Willingness to Use Prep Among Prep Naïve Men Who Have Sex with Men: A Meta-Analysis and Systematic Review

    Jun 1, 2023, 00:00

  • MT11 Field Testing of a Novel Holistic National Health Outcome Score: An Indicator of Health from Patient-Reported Outcomes

    Jun 1, 2023, 00:00

  • HPR58 A Tale of Two Drugs: How the Inflation Reduction Act of 2022 Impacts Drug Classes Differently

    Jun 1, 2023, 00:00

  • MT15 Adherence to Positive Airway Pressure Therapy in a Cohort of Colombian Patients with Obstructive Sleep Apnea Syndrome

    Jun 1, 2023, 00:00

  • CO198 Anatomical Characterization of Long Bone Femur and Tibial Fractures and Associated Two-Year Risks of Non-Union – A US Database Analysis

    Jun 1, 2023, 00:00

  • MT44 A Systematic Literature Review and Meta-Analysis of Randomized Controlled Trials Comparing Robotic Assisted Cancer Surgery with the Laparoscopic or Open Approach

    Jun 1, 2023, 00:00

  • MT47 Does the Use of New Technology By Care Managers Have an Impact on Neonatal Intensive Care Unit (NICU) Admissions and Length of Stay?

    Jun 1, 2023, 00:00

  • MSR30 Comparison of Search Design and Output of Embase Using Two Different Search Interfaces: Embase.com and OVID

    Jun 1, 2023, 00:00

  • MSR50 A Practical Method for Determining the Optimal Allocation between Computation Time and Accuracy in Probabilistic Patient-Level Microsimulation Models

    Jun 1, 2023, 00:00

  • EE177 Topical Sirolimus 0.2% Gel for Treatment of Facial Angiofibroma Associated with Tuberous Sclerosis Complex in the United States: A Budget Impact Analysis

    Jun 1, 2023, 00:00

  • EPH41 Association of Ustekinumab with Carpal Tunnel Syndrome, Cutaneous Lupus Erythematosus, Basedow's Disease and Melanocytic Naevus: A Disproportionality Analysis in Usfda Adverse Event Reporting System Database

    Jun 1, 2023, 00:00

  • Award Winners

    Jun 1, 2023, 00:00

  • P59 Medication Adherence and Subsequent Year Payer Medical Costs Among Medicare Advantage Beneficiaries: Differences across Quality Measures

    Jun 1, 2023, 00:00

  • PCR141 What Drives the Views of Young People (16–23 YEARS) and Parents on Invasive Meningococcal Disease and Their Willingness to Vaccinate?

    Jun 1, 2023, 00:00

  • EPH178 Disease Burden, Treatment Landscape, and Health Related Quality of Life Outcomes in Myasthenia Gravis: Results from the Adelphi Real World Disease Specific Programme in the United States and Europe

    Jun 1, 2023, 00:00

  • HPR25 An Assessment of Value-Based Health Care Elements in Colombia

    Jun 1, 2023, 00:00

  • EE511 Modeling Approaches in the Cost-Effectiveness Analysis of Cancer Treatments: A Review of Submissions Made to the Canadian Agency for Drugs and Technologies in Health

    Jun 1, 2023, 00:00

  • EE189 Cost-Effectiveness Analysis of Dupilumab in Severe Atopic Dermatitis Patients Aged >= 6 Years Old Who Have Failed to Topical Therapies or When Those Therapies Are Not Recommended

    Jun 1, 2023, 00:00

  • EPH101 Medication Adherence in Egypt: A Systematic Review

    Jun 1, 2023, 00:00

  • HTA11 Challenges in Establishing a National Health Technology Assessment Agency in the United States: Insight from Low- and Middle-Income Countries

    Jun 1, 2023, 00:00

  • EE197 Cost-Effectiveness of Monoclonal Antibodies (MABs) for Rheumatoid Arthritis (RA) in the United States

    Jun 1, 2023, 00:00

  • HTA12 Key Features and Challenges of Cell and Gene Therapies Highlighted in Health Technology Assessment (HTA) Submissions

    Jun 1, 2023, 00:00

  • MSR10 A Preliminary Assessment of Sample Size As a Search Strategy Filter on Embase.Com in Targeted Literature Searches

    Jun 1, 2023, 00:00

  • CO210 Real-World Effectiveness and Treatment Patterns of Venetoclax-Based Regimens Among Patients with Chronic Lymphocytic Leukemia (CLL) Treated in Community Settings

    Jun 1, 2023, 00:00

  • HSD64 Biologics Vs. Biosimilars Utilization Among Rheumatoid Arthritis (RA) Patients

    Jun 1, 2023, 00:00

  • RWD89 Risk of Electrolyte Imbalance in Elderly Colorectal Cancer Patients Following Treatment with Metformin Vs Sulfonylureas

    Jun 1, 2023, 00:00

  • PCR51 Qualitative Synthesis of Cognitive Debriefing and Usability Testing Studies to Inform Good Electronic Clinical Outcome Assessment Design

    Jun 1, 2023, 00:00

  • RWD20 Analysis of US Real World Evidence Data to Assess and Compare the Effectiveness of Two Chemotherapy Regimens: FOLFIRINOX Vs Gemcitabine/Nab-paclitaxel for First Line Metastatic Pancreatic Cancer

    Jun 1, 2023, 00:00

  • MSR87 Reviewing Elements to Inform Re-Running Searches: Refreshing Systematic Literature Reviews

    Jun 1, 2023, 00:00

  • EE194 Marginal Healthcare Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Chronic Kidney Disease: 2011-2020

    Jun 1, 2023, 00:00

  • EE156 Budget Impact Analysis of Inotuzumab Ozogamicin for the Treatment of Adults with Relapsed or Refractory Acute Lymphoblastic Leukemia in Colombia

    Jun 1, 2023, 00:00

  • SA11 Evaluating the Adherence to ISPOR Guidelines in US Published Budget Impact Analyses of New Drugs: A Targeted Literature Review

    Jun 1, 2023, 00:00

  • EE331 Leveraging Time-Use Data to Estimate Market and Non-Market Productivity Losses Due to Respiratory Syncytial Virus (RSV) Disease Among Adults Aged ≥60 Years in the United States (US)

    Jun 1, 2023, 00:00

  • HSD56 Provider Perceptions Impacting Treatment Choice in Mantel Cell Lymphoma (MCL): An Analysis of the Shine Trial Evaluating Ibrutinib + Bendamustine and Rituximab (I+BR) Versus Bendamustine and Rituximab (BR) in First-Line (1L)

    Jun 1, 2023, 00:00

  • P32 Psychometric Evaluation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire–Core 30-Items and Myeloma 20-Item Module in Multiple Myeloma Patients

    Jun 1, 2023, 00:00

  • RWD80 Use of Ml Model to Predict Biologic to Biosimilar Switch in Inflammatory Bowel Disease

    Jun 1, 2023, 00:00

  • PCR249 Advancing Equity, Diversity, Inclusion, and Belonging in Patient Centered Drug Development with Patient Preference Research

    Jun 1, 2023, 00:00

  • CO11 Systematic Literature Review to Evaluate Randomized Clinical Trials of Advanced Therapies for Moderate to Severe Crohn's Disease

    Jun 1, 2023, 00:00

  • SA62 Prescribing Patterns and Preference Attributes of Novel Oral Anticoagulants in Atrial Fibrillation and Venous Thromboembolism in Real-World Practice in China: A Nationwide Physician Survey

    Jun 1, 2023, 00:00

  • EPH184 Prevalence of Acute Myeloid Leukemia in the United States: A Cross-Sectional Study Using the SEER Database

    Jun 1, 2023, 00:00

  • EE139 Cost-Effectiveness of Aducanumab Versus Donepezil for Patients with Early Alzheimer's Disease

    Jun 1, 2023, 00:00

  • EE202 Cost-Effectiveness of Dolutegravir Versus Efavirenz-Based Combined Antiretroviral Regimens in HIV Infected Treatment-Naïve Patients at Nigeria’s University College Hospital.

    Jun 1, 2023, 00:00

  • RWD26 Variation in Demographic Characteristics, Socioeconomic Status, Clinical Presentation and Selected Treatments in Mortality Among Patients with a Diagnosis of COVID-19 in the United States

    Jun 1, 2023, 00:00

  • MSR46 ADTs Drive Real-Time Readmission Prediction for Blue Cross and Blue Shield of Louisiana Members: A Model Evaluation

    Jun 1, 2023, 00:00

  • HPR5 Minimally Invasive Thyroidectomy Implementation for Cancer Care: Do Racial, Ethnic and Insurance Characteristics Play a Role?

    Jun 1, 2023, 00:00

  • P36 Navigating the Digital Health Landscape for Chronic Disease Management: A Value Assessment Framework for Patient-Facing Technologies

    Jun 1, 2023, 00:00

  • PCR133 Somatotrophin Treatment Patterns: Real-World Data from Argentina

    Jun 1, 2023, 00:00

  • PCR247 Relation of Patient Activation to Medication Adherence in Low-Literacy Older Adults with Chronic Health Conditions

    Jun 1, 2023, 00:00

  • MSR81 Vaccine Rate Coverage Forecast in Brazil: Is It Possible to Keep Polio Eradicated?

    Jun 1, 2023, 00:00

  • EE490 A Real-World Assessment of Healthcare Costs Related to Agitation Associated with Alzheimer's Dementia

    Jun 1, 2023, 00:00

  • HSD50 Landscape and Management Strategies of Obesity in Older Adults Enrolled in Humana Medicare Advantage Plans

    Jun 1, 2023, 00:00

  • EPH242 Adherence and Factors Associated with Cotrimoxazole Preventive Therapy Among Adult Human Immunodeficiency Virus (HIV) Patients Attending Antiretroviral Clinics in Jigjiga Hospitals

    Jun 1, 2023, 00:00

  • EE171 Time to Diagnosis and Cost Effectiveness of Whole Exome Sequencing (WES) Position in the Diagnostic Pathways of Patients with Suspected Rare Genetic Disease

    Jun 1, 2023, 00:00

  • PCR236 Impact of Clinical Features on Patient Reported Outcomes and Treatment Satisfaction in Psoriatic Arthritis

    Jun 1, 2023, 00:00

  • CO68 Simulated mOS of Gemcitabine+Carboplatin ± Maintenance Avelumab Therapy or Enfortumab Vedotin + Pembrolizumab in First-Line Treatment of LA/mUC in Patients Ineligible for Cisplatin Using Disease Modeling

    Jun 1, 2023, 00:00

  • PCR221 Measurement and Analysis of Health-Related Quality of Life Data in Cancer Drug Trials: A Review of Post-Reimbursement Data

    Jun 1, 2023, 00:00

  • EE17 Societal Cost of Racial Disparities in Pneumococcal Disease in U.S. Adults Aged 50 Years or Older

    Jun 1, 2023, 00:00

  • CO55 Psychometric Evaluation of the Measurement Properties of a Pediatric Clinical Outcome Assessment for Functional Constipation: Data from a Phase 3 Clinical Trial

    Jun 1, 2023, 00:00

  • CO83 IV Iron Treatment Episodes Among US Patients with Iron Deficiency Anemia

    Jun 1, 2023, 00:00

  • EE326 Malnutrition Prevalence and Economic Burden Among US Hospitalized Older Adult Patients with and without COVID-19

    Jun 1, 2023, 00:00

  • HTA59 Anticipating Market Access Challenges in Canada for Lecanemab: Learnings from Previous Health Technology Assessments of Disease-Modifying Therapies in Neurodegenerative Diseases

    Jun 1, 2023, 00:00

  • EE543 The Impact of Different Utility Values on a Cost-Effectiveness Model in Diabetic Macular Edema

    Jun 1, 2023, 00:00

  • SA55 Considerations for Common Exclusion Criteria in Real-World (RW) Retrospective Observational Studies in Oncology

    Jun 1, 2023, 00:00

  • CO35 Real-World Effectiveness of Intravitreal Ranibizumab and Aflibercept for Eyes with Central Retinal Vein Occlusion: A Multi-Institutional Cohort Study in Taiwan

    Jun 1, 2023, 00:00

  • HPR3 Why the Increase? Drilling Down on Increases in Prescribed Medication Expenditures in the United States between 2011 and 2020: Findings from the Medical Expenditures Panel Survey

    Jun 1, 2023, 00:00

  • HSD23 Comparison of Drug Utilization Outcomes of Direct Oral Anticoagulants in Medicare Patients

    Jun 1, 2023, 00:00

  • EE375 Work and Activity Impairment in Huntington Disease

    Jun 1, 2023, 00:00

  • HPR105 Impact of Social Determinants of Health on Access to Device Aided Therapy Services for Medicare Fee-for-Service Beneficiaries with Advanced Parkinsons Disease

    Jun 1, 2023, 00:00

  • OP5 Cost-Shifting Practices in Hospitals: A Systematic Review

    Jun 1, 2023, 00:00

  • EE68 Cost-Effectiveness of Using a Novel Machine Learning Algorithm to Diagnose Idiopathic Pulmonary Fibrosis

    Jun 1, 2023, 00:00

  • CO45 Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults with Chronic Plaque Psoriasis from a 52-Week, Phase 2 Open-Label Safety Trial

    Jun 1, 2023, 00:00

  • EPH90 Incidence Rate of Infections and Association between Lupus Nephritis and Serious Infections in Patients with Systemic Lupus Erythematosus: Systematic Literature Review and Meta-Analyses

    Jun 1, 2023, 00:00

  • HTA26 Duration and Timing of Treatment Waning: Determining the Start and Stop Points Using Pembrolizumab in NSCLC As a Case Study

    Jun 1, 2023, 00:00

  • MSR36 How Does the Use of Different Targeted Literature Review (TLR) Methodologies Impact the Research Output? a Case Study of Structured Vs. Focused Vs. Pearl Growing Approach

    Jun 1, 2023, 00:00

  • RWD11 Occurrence and Severity of Depression, Antidepressant Use Among Alzheimer’s Disease (AD) Patients across Race/Ethnicity

    Jun 1, 2023, 00:00

  • CO39 Real-World Assessment of Efficacy and Safety of Natalizumab Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Systematic Review and Meta-Analysis

    Jun 1, 2023, 00:00

  • MT30 Medtech Innovations in Oncology: A Review of NICE Medtech Innovation Briefings from 2014 to 2022

    Jun 1, 2023, 00:00

  • PCR216 Insights from Social Media Posts on the Lived Experience of Alzheimer's Disease

    Jun 1, 2023, 00:00

  • PCR117 Meaningful Change Thresholds in Patient-Reported Outcome Scores for Patients with Colorectal Cancer – A Systematic Literature Review

    Jun 1, 2023, 00:00

  • HPR47 Access to Prenatal Care and Poverty in Colombian Regions: Before and in the Pandemic

    Jun 1, 2023, 00:00

  • EPH230 Estimating Risk of Disease Progression from Mild Cognitive Impairment (MCI) to Alzheimer’s Disease (AD) Using Administrative Claims

    Jun 1, 2023, 00:00

  • SA28 Review of Machine Learning Based Disease Diagnosis Modeling

    Jun 1, 2023, 00:00

  • HPR70 Therapeutic Preference for Alzheimer’S Disease Treatments: A Discrete Choice Experiment (DCE) with Caregivers and Neurologists

    Jun 1, 2023, 00:00

  • HTA28 Evaluation of the Cost-Effectiveness of Laparoscopic Partial Nephrectomy in Comparison with Open Partial Nephrectomy

    Jun 1, 2023, 00:00

  • HPR120 The Pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A Comparative Study Using Donabedian's Structure-Process-Outcome Framework

    Jun 1, 2023, 00:00

  • EE381 Cost-Effectiveness Analysis of Active Surveillance Compared to Early Surgery in Small Papillary Thyroid Cancer with the Previous Data in Korean Population

    Jun 1, 2023, 00:00

  • EE30 Annual Disability-State Transition Probabilities Estimated from a Large Sample (>6000) of Australians with Multiple Sclerosis from MS-Base

    Jun 1, 2023, 00:00

  • HSD22 Understanding Barriers and Facilitators to Prescribing Sodium-Glucose Trasnporter-2 Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction

    Jun 1, 2023, 00:00

  • EE58 Healthcare Resource Utilization Among Patients with Transfusion-Dependent Beta-Thalassemia in Italy

    Jun 1, 2023, 00:00

  • RWD19 Comparative Effectiveness Using External Controls for Single-Arm Trials of Pembrolizumab in Tumor-Agnostic Indications Leveraging Real-World Data

    Jun 1, 2023, 00:00

  • HPR129 Is Cost-Effectiveness Analysis a Tool to Exercise Value-Based Pricing or Monopsony Power? Evidence from Canada and Other Countries

    Jun 1, 2023, 00:00

  • PCR166 PRO Reporting and Methodological Rigor in NSCLC RCTs, a Cause for Concern

    Jun 1, 2023, 00:00

  • EE88 Cost-Effectiveness Analysis of Etodolac and Aceclofenac in Low Back Pain

    Jun 1, 2023, 00:00

  • P50 Using Biomarker Change and Treatment Adherence to Predict Risk of Relapse Among Chronic Myeloid Leukemia Patients Who Are in Remission

    Jun 1, 2023, 00:00

  • PCR93 Effect of Physicians’ Prescribing Choices of First- or Second-Line Tumor Necrosis Factor Inhibitor Biologics Versus Non-Tumor Necrosis Factor Inhibitor Biologic Therapies on Psoriatic Arthritis Patient-Reported Outcomes

    Jun 1, 2023, 00:00

  • RWD38 Quality of Electronic Health Records: Managing Aggregated Patient Demographic Information

    Jun 1, 2023, 00:00

  • MT52 Real World Utilization of Digital Therapeutics: A Review

    Jun 1, 2023, 00:00

  • OP10 Safety Monitoring of Orphan Drugs Project: SFDA Experience

    Jun 1, 2023, 00:00

  • Editorial Board

    May 1, 2023, 08:40

  • Caregiving-Related Work Productivity Loss Among Employed Family and Other Unpaid Caregivers of Older Adults

    May 1, 2023, 00:00

  • Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: Opening the Gates for Faithful Migration

    May 1, 2023, 00:00

  • Health and Economic Evaluation of Vaccination Against Pertussis in China: A 40-Year Analysis

    May 1, 2023, 00:00

  • The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom

    May 1, 2023, 00:00

  • Cost-Effectiveness of Medication Therapy Management Program Across Racial and Ethnic Groups Among Medicare Beneficiaries [Editor's Choice]

    May 1, 2023, 00:00

  • Twenty-Five Years of Health Economics and Outcomes Research: An Exploration of Value in Health

    May 1, 2023, 00:00

  • Economic Evaluation of Elective Cesarean Section on Maternal Request Compared With Planned Vaginal Birth—Application to Swedish Setting Using National Registry Data

    May 1, 2023, 00:00

  • Economic Evaluation of Family-Focused Programs When Parents Have a Mental Health Problem: Methodological Considerations

    May 1, 2023, 00:00

  • Table of Contents

    May 1, 2023, 00:00

  • Censoring Time Trade-off Values at 0 Versus at −1: How Does the Assumption for Worse-Than-Dead Time Trade-off Values Affect the Modeling of EQ-5D-5L Valuation Data?

    May 1, 2023, 00:00

  • Developing Prioritization Criteria to Identify Target Drugs for CalRx, the California Generic Drugs Initiative

    May 1, 2023, 00:00

  • The Impact of Reimbursement for Non-Face-to-Face Chronic Care Management on Health Utilization Among Patients With Type 2 Diabetes in Louisiana

    May 1, 2023, 00:00

  • The Cost-Effectiveness of Financial Incentives to Achieve Heroin Abstinence in Individuals With Heroin Use Disorder Starting New Treatment Episodes: A Cluster Randomized Trial-Based Economic Evaluation

    May 1, 2023, 00:00

  • Copyright/Subscription

    May 1, 2023, 00:00

  • EQ-5D-3L Norms for the European Older Population: Country-Specific Norms for 15 European Countires Based on the Survey of Health, Ageing, and Retirement in Europe

    May 1, 2023, 00:00

  • Comparisons in the Health and Economic Assessments of Using Quadrivalent Versus Trivalent Influenza Vaccines: A Systematic Literature Review

    May 1, 2023, 00:00

  • Updated Recommendations on Evidence Needed to Support Measurement Comparability Among Modes of Data Collection for Patient-Reported Outcome Measures: A Good Practices Report of an ISPOR Task Force

    May 1, 2023, 00:00

  • Dealing With Uncertainty in Early Health Technology Assessment: An Exploration of Methods for Decision Making Under Deep Uncertainty [Editor's Choice]

    May 1, 2023, 00:00

  • Assessing Outcomes for Cost-Utility Analysis in Children and Adolescents With Mental Health Problems: Are Multiattribute Utility Instruments Fit for Purpose?

    May 1, 2023, 00:00

  • Estimating Joint Health State Utility Algorithms Under Partial Information

    May 1, 2023, 00:00

  • Do Misconceptions About Health-Related Quality of Life Affect General Population Valuations of Health States? [Editor's Choice]

    May 1, 2023, 00:00

  • The Use of Multicriteria Decision Analysis to Support Decision Making in Healthcare: An Updated Systematic Literature Review [Editor's Choice]

    May 1, 2023, 00:00

  • Editorial Board

    Apr 20, 2023, 10:47

  • Editorial Board

    Apr 2, 2023, 08:18

  • Table of Contents

    Apr 1, 2023, 00:00

  • Reducing Hospital Capacity Needs for Seasonal Respiratory Infections: The Case of Switching to High-Dose Influenza Vaccine for Dutch Older Adults

    Apr 1, 2023, 00:00

  • Table of Contents

    Apr 1, 2023, 00:00

  • Structure and Content of a Taxonomy to Support the Use of Real-World Evidence by Health Technology Assessment Practitioners and Healthcare Decision Makers

    Apr 1, 2023, 00:00

  • Development of the Cystic Fibrosis Questionnaire-Revised-8 Dimensions: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised [EDITOR'S CHOICE]

    Apr 1, 2023, 00:00

  • Data Governance for Real-World Data Management: A Proposal for a Checklist to Support Decision Making

    Apr 1, 2023, 00:00

  • Using Real-World Data in the Health Technology Assessment of Pharmaceuticals: Strengths, Difficulties, and a Pragmatic Way Forward

    Apr 1, 2023, 00:00

  • Reviewer Acknowledgment

    Apr 1, 2023, 00:00

  • Cost-Effectiveness of Venetoclax Plus Obinutuzumab Versus Chlorambucil Plus Obinutuzumab for the First-Line Treatment of Adult Patients With Chronic Lymphocytic Leukemia: An Extended Societal View

    Apr 1, 2023, 00:00

  • A Conceptual Framework for Life-Cycle Health Technology Assessment

    Apr 1, 2023, 00:00

  • EUreccA 2025: A Multistakeholder Effort to Further Real-World Evidence in Healthcare Decision Making

    Apr 1, 2023, 00:00

  • Pneumococcal Vaccination in Children: A Systematic Review and Meta-Analysis of Cost-Effectiveness Studies

    Apr 1, 2023, 00:00

  • Copyright/Subscription

    Apr 1, 2023, 00:00

  • Approaches to the Assessment of Clinical Benefit of Treatments for Conditions That Have Heterogeneous Symptoms and Impacts: Potential Applications in Rare Disease

    Apr 1, 2023, 00:00

  • The Real-World Evidence Workstream in EUreccA 2025: How the Task Was Addressed

    Apr 1, 2023, 00:00

  • Across-Country Variations of Real-World Data and Evidence for Drugs: A 5-European-Country Study

    Apr 1, 2023, 00:00

  • Author Reply

    Apr 1, 2023, 00:00

  • Cost-Effectiveness of Tepotinib Versus Capmatinib for the Treatment of Adult Patients With Metastatic Non–Small Cell Lung Cancer Harboring Mesenchymal–Epithelial Transition Exon 14 Skipping

    Apr 1, 2023, 00:00

  • Suitability of Preference Methods Across the Medical Product Lifecycle: A Multicriteria Decision Analysis

    Apr 1, 2023, 00:00

  • Lost Therapeutic Benefit of Delayed Low-Density Lipoprotein Cholesterol Control in Statin-Treated Patients and Cost-Effectiveness Analysis of Lipid-Lowering Intensification

    Apr 1, 2023, 00:00

  • Between-Hospital and Between-Physician Variation in Outcomes and Costs in High- and Low-Complex Surgery: A Nationwide Multilevel Analysis

    Apr 1, 2023, 00:00

  • Mapping Studies to Estimate Health-State Utilities From Nonpreference-Based Outcome Measures: A Systematic Review on How Repeated Measurements are Taken Into Account [EDITOR'S CHOICE]

    Apr 1, 2023, 00:00

  • An Analysis of Accessibility of Representative Psychotropic Medicine From the World Health Organization Model List of Essential Medicines in Developing Countries With Different Income Levels

    Apr 1, 2023, 00:00

  • Interaction Effects in Health State Valuation Studies: An Optimal Scaling Approach

    Apr 1, 2023, 00:00

  • A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma

    Apr 1, 2023, 00:00

  • Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task Force [EDITOR'S CHOICE]

    Apr 1, 2023, 00:00

  • Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque Psoriasis

    Apr 1, 2023, 00:00

  • Cost-Effectiveness of Respiratory Syncytial Virus Preventive Interventions in Children: A Model Comparison Study

    Apr 1, 2023, 00:00

  • Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Step Forward [EDITOR'S CHOICE]

    Apr 1, 2023, 00:00

  • Editorial Board

    Mar 2, 2023, 08:26

  • The Value of Medical Innovation Versus Industry Rewards

    Mar 1, 2023, 00:00

  • Equitable Prioritization of Health Interventions by Incorporating Financial Risk Protection Weights Into Economic Evaluations [Editor's Choice]

    Mar 1, 2023, 00:00

  • Drug Pricing Throughout the Product Lifecycle: A Work in Progress [Editor's Choice]

    Mar 1, 2023, 00:00

  • Use of Structured Template and Reporting Tool for Real-World Evidence for Critical Appraisal of the Quality of Reporting of Real-World Evidence Studies: A Systematic Review

    Mar 1, 2023, 00:00

  • Cost-Effectiveness of First-Line Pembrolizumab Monotherapy Versus Chemotherapy in High Programmed Death-Ligand 1 Advanced Non–Small Cell Lung Cancer in the Irish Healthcare Setting

    Mar 1, 2023, 00:00

  • Table of Contents

    Mar 1, 2023, 00:00

  • Medicare Drug Price Negotiation in the United States: Implications and Unanswered Questions [Editor's Choice]

    Mar 1, 2023, 00:00

  • Measuring Health and Well-Being: We Need to Get it Right for Patients, With Patients

    Mar 1, 2023, 00:00

  • Value-Based Pricing for Patent-Protected Medicines Over the Product Life Cycle: Pricing Anomalies in the “Age of Cures” and Their Implications for Dynamic Efficiency [Editor's Choice]

    Mar 1, 2023, 00:00

  • Author Reply

    Mar 1, 2023, 00:00

  • Modeling Tiered Pricing Frameworks: A Simulation Approach

    Mar 1, 2023, 00:00

  • The Influence of US Drug Price Dynamics on Cost-Effectiveness Analyses of Biologics

    Mar 1, 2023, 00:00

  • The Zero-Price Conundrum: Exploration of Scenarios Where a Clinically Effective New Drug Might Not Be Cost-Effective at Zero Price

    Mar 1, 2023, 00:00

  • Copyright/Subscription

    Mar 1, 2023, 00:00

  • The Impact on Cost-Effectiveness of Accounting for Generic Drug Pricing: Four Case Studies [Editor's Choice]

    Mar 1, 2023, 00:00

  • Innovative Public Price Mechanisms for Market Access of Innovative Medicines: A Marriage Between Cost-Effectiveness, Medical Need, and Budget Impact

    Mar 1, 2023, 00:00

  • How Much Does the US Public Value Equity in Health? A Systematic Review

    Mar 1, 2023, 00:00

  • Does the United States Need Better Policies Governing Generic Drug Use?

    Mar 1, 2023, 00:00

  • Using Multiple Authorized Generics to Maintain High Prices: The Example of Entacapone

    Mar 1, 2023, 00:00

  • The “Affordable Medicines” Reimbursement Program in Ukraine: Framework Assessment and Impact Evaluation

    Mar 1, 2023, 00:00

  • The Allocation of the Economic Value of Second-Generation Antipsychotics Over the Product Life Cycle: The Case of Risperidone in Sweden and the United Kingdom

    Mar 1, 2023, 00:00

  • Editorial Board

    Feb 7, 2023, 10:35

  • Cost-Effectiveness Analysis of Vaccination With Recombinant Zoster Vaccine Among Hematopoietic Cell Transplant Recipients and Persons With Other Immunocompromising Conditions Aged 19 to 49 Years

    Feb 1, 2023, 00:00

  • Preferences for Sexually Transmitted Infection and Cancer Vaccines in the United States and in China

    Feb 1, 2023, 00:00

  • Modifying the Composite Time Trade-Off Method to Improve Its Discriminatory Power

    Feb 1, 2023, 00:00

  • Table of Contents

    Feb 1, 2023, 00:00

  • Cost-Effectiveness Analysis of Treating Patients With NTRK-Positive Cancer With the Histology-Independent Therapy Entrectinib [Editor's Choice]

    Feb 1, 2023, 00:00

  • Can Observational Analyses of Routinely Collected Data Emulate Randomized Trials? Design and Feasibility of the Observational Patient Evidence for Regulatory Approval Science and Understanding Disease Project

    Feb 1, 2023, 00:00

  • The Impact of Sharing Drug Rebates at the Point of Sale on Out-of-Pocket Payments for Enrollees in Employer-Sponsored Insurance

    Feb 1, 2023, 00:00

  • Copyright/Subscription

    Feb 1, 2023, 00:00

  • Disease-Related Loss to Government Funding: Longitudinal Analysis of Individual-Level Health and Tax Data for an Entire Country

    Feb 1, 2023, 00:00

  • Quality-Adjusted Life Expectancy Norms for the English Population [Editor's Choice]

    Feb 1, 2023, 00:00

  • Navigating Patient-Preference Studies for Cross-Stakeholder Decision Making: A Roadmap Guides the Way

    Feb 1, 2023, 00:00

  • A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force [Editor's Choice]

    Feb 1, 2023, 00:00

  • A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 1—Data From Wearable Devices [Editor's Choice]

    Feb 1, 2023, 00:00

  • The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis

    Feb 1, 2023, 00:00

  • Generic Health-Related Quality of Life Utility Measure for Preschool Children (Health Utilities Preschool): Design, Development, and Properties

    Feb 1, 2023, 00:00

  • Is Intention to Treat Still the Gold Standard or Should Health Technology Assessment Agencies Embrace a Broader Estimands Framework? [Editor's Choice]

    Feb 1, 2023, 00:00

  • A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies

    Feb 1, 2023, 00:00

  • The Prader-Willi Syndrome Anxiousness and Distress Behaviors Questionnaire: Development and Psychometric Validation

    Feb 1, 2023, 00:00

  • Gradient Boosted Tree Approaches for Mapping European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 Onto 5-Level Version of EQ-5D Index for Patients With Cancer

    Feb 1, 2023, 00:00

  • Comprehensive Score for Financial Toxicity and Health-Related Quality of Life in Patients With Cancer and Survivors: A Systematic Review and Meta-Analysis

    Feb 1, 2023, 00:00

  • Editorial Board

    Jan 9, 2023, 08:36

  • Distributional Cost-Effectiveness Analysis of Health Technologies: Data Requirements and Challenges [Editor's Choice]

    Jan 1, 2023, 00:00

  • Challenges for Economic Evaluations of Advanced Therapy Medicinal Products: A Systematic Review [Editor's Choice]

    Jan 1, 2023, 00:00

  • Patient-Reported Satisfaction, Experiences, and Preferences: Same but Different? [Editor's Choice]

    Jan 1, 2023, 00:00

  • Cost-Effectiveness and Budget Impact of Future Developments With Whole-Genome Sequencing for Patients With Lung Cancer

    Jan 1, 2023, 00:00

  • Valuing Health Gain from Composite Response Endpoints for Multisystem Diseases

    Jan 1, 2023, 00:00

  • Heterogeneous Preferences for Colorectal Cancer Screening in Germany: Results of a Discrete Choice Experiment

    Jan 1, 2023, 00:00

  • Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids

    Jan 1, 2023, 00:00

  • Enhancing Patient Centricity of Real-World Data Research: An Exploratory Analysis Using the Patient Experience Mapping Toolbox

    Jan 1, 2023, 00:00

  • Assessment of the Social Security Administration Death Master File for Comparative Analysis Studies of Peripheral Vascular Devices

    Jan 1, 2023, 00:00

  • Patient Expectations About Palliative Treatment for Symptomatic Spinal Metastases: A Qualitative Study

    Jan 1, 2023, 00:00

  • Cost-Effectiveness of a Specialized Breathlessness Service Versus Usual Care for Patients With Advanced Diseases

    Jan 1, 2023, 00:00

  • For Me or for My Relatives? Approximating Self-Protection and Local Altruistic Motivations Underlying Preferences for Public Health Policies Using Risk Perception Metrics

    Jan 1, 2023, 00:00

  • A Data-Driven Approach to Support the Understanding and Improvement of Patients’ Journeys: A Case Study Using Electronic Health Records of an Emergency Department

    Jan 1, 2023, 00:00

  • Table of Contents

    Jan 1, 2023, 00:00

  • The Effect of the Drug Life Cycle Price on Cost-Effectiveness: Case Studies Using Real-World Pricing Data [Editor's Choice]

    Jan 1, 2023, 00:00

  • Test-Retest Reliability of EQ-5D-Y-3L Best-Worst Scaling Choices of Adolescents and Adults

    Jan 1, 2023, 00:00

  • Developing Patient-Centered Real-World Evidence: Emerging Methods Recommendations From a Consensus Process

    Jan 1, 2023, 00:00

  • Matching-Adjusted Indirect Comparisons of Lorlatinib Versus Chemotherapy for Patients With Second-Line or Later Anaplastic Lymphoma Kinase–Positive Non–Small Cell Lung Cancer

    Jan 1, 2023, 00:00

  • Copyright/Subscription

    Jan 1, 2023, 00:00

  • Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review

    Jan 1, 2023, 00:00

  • CO117 Assessing the Impact of Hospital Characteristics on Outcomes of Outpatient Cardiac Procedures: An Analysis of the HCUP-NASS 2019 Database

    Dec 14, 2022, 09:50

  • EPH112 Assessment of Consumption of Antidepressants in Ukraine Compared With Estonia

    Dec 1, 2022, 00:00

  • PCR210 Quality of Life and Productivity Losses of Dysmenorrhea Patients in Korea

    Dec 1, 2022, 00:00

  • MSR21 Exploration of the Impact of the Treatment Mechanism of Action on the Surrogate Relationship Between Progression Free Survival and Overall Survival in Metastatic Colorectal Cancer

    Dec 1, 2022, 00:00

  • HTA154 Comparing Non-Oncological Rare Condition Submissions to the National Institute for Health and Care Excellence (NICE) Versus Scottish Medicines Consortium (SMC) From 2001 to 2021

    Dec 1, 2022, 00:00

  • PCR108 Using the Medication Adherence Reasons Scale (MAR-SCALE) in Asthma and Chronic Obstructive Pulmonary Disease to Identify and Describe Reasons for Non-Adherence in 5 European Countries

    Dec 1, 2022, 00:00

  • EE248 Cost Effectiveness of Novel Antiobiotic Imipenem/Cilastatin/Relebactam in Gram Negative Infections in Greece

    Dec 1, 2022, 00:00
  • «
  • 21 (current)
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • »